StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
164
Publishing Date
2023 - 01 - 09
2
2022 - 06 - 02
3
2022 - 04 - 08
2
2022 - 03 - 30
2
2022 - 01 - 05
2
2021 - 12 - 27
2
2021 - 11 - 22
2
2021 - 11 - 10
2
2021 - 10 - 21
22
2021 - 10 - 04
2
2021 - 09 - 30
1
2021 - 09 - 29
2
2021 - 09 - 27
1
2021 - 09 - 24
1
2021 - 09 - 23
2
2021 - 09 - 22
2
2021 - 09 - 17
1
2021 - 09 - 16
1
2021 - 09 - 13
1
2021 - 09 - 09
1
2021 - 09 - 07
1
2021 - 09 - 01
1
2021 - 08 - 16
1
2021 - 08 - 11
1
2021 - 08 - 09
2
2021 - 08 - 06
1
2021 - 07 - 30
1
2021 - 07 - 29
1
2021 - 07 - 23
1
2021 - 07 - 19
1
2021 - 07 - 14
1
2021 - 07 - 09
2
2021 - 06 - 24
2
2021 - 06 - 22
1
2021 - 06 - 18
1
2021 - 06 - 17
2
2021 - 06 - 16
1
2021 - 06 - 09
2
2021 - 06 - 02
2
2021 - 06 - 01
1
2021 - 05 - 28
1
2021 - 05 - 19
2
2021 - 05 - 14
2
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 05 - 04
1
2021 - 04 - 30
1
2021 - 04 - 27
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 15
2
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 12
3
2021 - 04 - 09
1
2021 - 04 - 08
1
2021 - 04 - 07
2
2021 - 04 - 05
2
2021 - 03 - 31
1
2021 - 03 - 30
1
Sector
Consumer non-durables
1
Health technology
164
Manufacturing
1
Tags
Aacr journals
1
Agreement
1
Als
1
Analytics
2
Annual needham
1
Annual needham virtual healthcare conference
1
Antibody
6
Application
6
Asco
1
Association
1
Biopharma
55
Bn301
1
Business
1
Cancer
10
Care
1
Ceo
3
Ces
1
China
2
Collaboration
4
Commercialization
1
Conference
32
Contract
8
Covid-19
1
Drug
6
Ev
2
Expansion
4
Financial
2
Financial results
3
Germany
1
Grant
3
Granted
1
Grants
4
Health
4
Immunology
3
Immunotherapy
1
License
1
Life
1
Life science
1
Medical
1
Meeting
7
Milestone
6
Molecular
1
N/a
164
Nasdaq
5
Needham virtual healthcare conference
1
Ovarian cancer
5
Partnership
1
Phase 1
5
Phase 2
2
Phase 3
2
Presentation
27
Program
1
Research
17
Results
3
Sciences
1
Stro-002
9
Study
2
Thc
3
Treatment
3
Update
3
Entities
Abbott laboratories
1
Astrazeneca plc
1
Kering
1
Nektar therapeutics
1
Palatin technologies, inc.
1
Sanofi
1
Sutro biopharma, inc.
164
Vaxcyte, inc.
13
Symbols
ABT
1
AZN
1
NKTR
1
PCVX
13
PPRUF
1
PPRUY
1
PTN
1
SNY
1
STRO
164
Exchanges
Amex
1
Nasdaq
164
Nyse
1
Crawled Date
2023 - 01 - 09
2
2022 - 06 - 02
3
2022 - 04 - 08
2
2022 - 03 - 30
2
2022 - 01 - 06
3
2021 - 12 - 27
2
2021 - 11 - 22
2
2021 - 11 - 10
2
2021 - 10 - 21
22
2021 - 10 - 04
2
2021 - 10 - 01
1
2021 - 09 - 30
1
2021 - 09 - 29
2
2021 - 09 - 27
1
2021 - 09 - 24
3
2021 - 09 - 23
1
2021 - 09 - 22
1
2021 - 09 - 17
1
2021 - 09 - 16
1
2021 - 09 - 13
1
2021 - 09 - 09
1
2021 - 09 - 07
1
2021 - 09 - 01
1
2021 - 08 - 16
1
2021 - 08 - 11
1
2021 - 08 - 09
2
2021 - 08 - 06
1
2021 - 07 - 30
1
2021 - 07 - 29
1
2021 - 07 - 23
1
2021 - 07 - 19
1
2021 - 07 - 15
1
2021 - 07 - 09
2
2021 - 06 - 24
2
2021 - 06 - 22
1
2021 - 06 - 18
1
2021 - 06 - 17
3
2021 - 06 - 09
2
2021 - 06 - 02
2
2021 - 06 - 01
1
2021 - 05 - 28
1
2021 - 05 - 19
2
2021 - 05 - 14
2
2021 - 05 - 07
1
2021 - 05 - 05
1
2021 - 05 - 04
1
2021 - 04 - 30
1
2021 - 04 - 27
1
2021 - 04 - 22
1
2021 - 04 - 20
1
2021 - 04 - 15
2
2021 - 04 - 14
1
2021 - 04 - 13
2
2021 - 04 - 12
2
2021 - 04 - 09
1
2021 - 04 - 08
1
2021 - 04 - 07
2
2021 - 04 - 05
2
2021 - 03 - 31
1
2021 - 03 - 30
1
Crawled Time
00:00
8
00:20
3
02:00
2
03:00
4
05:00
2
10:00
2
11:00
20
11:20
1
12:00
17
12:01
1
12:15
1
12:20
1
12:30
1
13:00
4
14:00
1
14:15
5
15:00
3
15:15
6
16:00
5
17:00
18
18:00
6
19:00
9
20:00
7
21:00
20
22:00
10
23:00
7
Source
alteritytherapeutics.com
65
apyxmedical.com
47
contravir.com
39
feed.businesswire.com
38
investor.alkermes.com
92
investor.assemblybio.com
44
investor.aveooncology.com
40
investors.biomarin.com
75
investors.phiopharma.com
35
ir.akerotx.com
45
ir.anaptysbio.com
30
ir.ateapharma.com
32
ir.auriniapharma.com
65
ir.biolinerx.com
35
ir.check-cap.com
29
ir.cyclerion.com
32
ir.kalvista.com
85
ir.therapeuticsmd.com
44
ir.vaccinex.com
33
ir.viveve.com
58
ir.voyagertherapeutics.com
29
ir.zynerba.com
27
jaguarhealth.gcs-web.com
189
mdxhealth.com
111
ocutx.gcs-web.com
32
spacfeed.com
1037
www.achievelifesciences.com
30
www.admabiologics.com
53
www.allogene.com
70
www.aquestive.com
36
www.arcadiabio.com
41
www.atyrpharma.com
33
www.biospace.com
28236
www.brainsway.com
208
www.catalent.com
30
www.celyad.com
38
www.clinuvel.com
105
www.crinetics.com
49
www.curevac.com
48
www.electromed.com
42
www.fatetherapeutics.com
150
www.fda.gov
152
www.globenewswire.com
25337
www.igcinc.us
36
www.inovio.com
30
www.inventivapharma.com
55
www.invobioscience.com
34
www.kuraoncology.com
34
www.modeln.com
46
www.nurixtx.com
55
www.oncocyte.com
239
www.pacb.com
29
www.ppdi.com
40
www.precisionbiosciences.com
31
www.predictmedix.com
39
www.prnewswire.com
18809
www.sutrobio.com
164
www.thermogenesis.com
53
www.vbivaccines.com
35
www.vynetherapeutics.com
114
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
source :
Www.sutrobio.com
save search
2023 American Society of Clinical Oncology (ASCO) Annual Meeting – Presentation
Published:
2023-06-03
(Crawled : 00:20)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
Email alert
Add to watchlist
presentation
meeting
Sutro Biopharma to Participate in the Jefferies Healthcare Conference
Published:
2023-05-31
(Crawled : 12:01)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-18.22%
|
O:
0.22%
H:
4.55%
C:
-2.81%
conference
biopharma
2023 American Society of Pediatric Hematology / Oncology (ASPHO) Annual Meeting – Poster
Published:
2023-05-17
(Crawled : 22:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-34.43%
|
O:
-1.04%
H:
0.18%
C:
-7.03%
meeting
Sutro Biopharma to Present at the JMP Securities Life Sciences Conference
Published:
2023-05-08
(Crawled : 12:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-31.2%
|
O:
-0.18%
H:
2.56%
C:
0.37%
conference
life
biopharma
sciences
Sutro Biopharma Announces the Departure of President of Research & Chief Scientific Officer
Published:
2023-04-27
(Crawled : 21:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-13.33%
|
O:
-0.69%
H:
1.16%
C:
-1.39%
biopharma
research
2023 American Association for Cancer Research Annual Meeting (AACR) – Poster
Published:
2023-04-18
(Crawled : 18:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-19.44%
|
O:
0.21%
H:
0.43%
C:
-3.84%
association
cancer
research
meeting
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
Published:
2023-03-30
(Crawled : 21:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-15.85%
|
O:
-0.89%
H:
6.31%
C:
4.05%
business
year
biopharma
financial
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-03-17
(Crawled : 20:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
Email alert
Add to watchlist
nasdaq
biopharma
grants
13th Annual World ADC London 2023 – Presentation
Published:
2023-03-14
(Crawled : 16:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-30.57%
|
O:
1.1%
H:
8.01%
C:
0.36%
presentation
Sutro Biopharma to Present at the Cowen 43rd Annual Health Care Conference
Published:
2023-03-01
(Crawled : 13:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-33.16%
|
O:
1.6%
H:
3.4%
C:
0.7%
biopharma
care
conference
health
Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer
Published:
2023-02-28
(Crawled : 13:00)
- sutrobio.com
ABT
|
News
|
$107.07
-0.2%
-0.09%
3.8M
|
Health Technology
|
7.32%
|
O:
0.07%
H:
2.58%
C:
1.88%
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-34.21%
|
O:
0.0%
H:
5.06%
C:
-1.57%
biopharma
medical
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-02-17
(Crawled : 21:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
Email alert
Add to watchlist
biopharma
nasdaq
grants
BioNova Announces First Patient Dosed in a Phase 1/2 Study of BN301 for the Treatment of Hematologic Malignancies in China
Published:
2023-02-13
(Crawled : 17:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-41.09%
|
O:
-0.31%
H:
8.62%
C:
-1.88%
bn301
treatment
china
study
phase 1
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers – Molecular Cancer Therapeutics – AACR Journals
Published:
2023-02-07
(Crawled : 00:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-46.14%
|
O:
0.14%
H:
0.0%
C:
-3.99%
stro-002
treatment
therapeutics
molecular
cancer
aacr journals
41st Annual JP Morgan Healthcare Conference – Presentation
Published:
2023-01-12
(Crawled : 19:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-50.85%
|
O:
5.08%
H:
4.22%
C:
-2.36%
conference
presentation
Update on STRO-002 Program and Plans for Registrational Trial in Advanced Ovarian Cancer – Presentation
Published:
2023-01-09
(Crawled : 23:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-54.52%
|
O:
1.93%
H:
0.89%
C:
-14.08%
stro-002
program
trial
presentation
update
cancer
ovarian cancer
Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer
Published:
2023-01-09
(Crawled : 22:00)
- sutrobio.com
PCVX
|
$61.6
1.27%
1.24%
630K
|
Health Technology
|
34.15%
|
O:
-0.3%
H:
1.79%
C:
0.35%
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-54.52%
|
O:
1.93%
H:
0.89%
C:
-14.08%
stro-002
biopharma
update
cancer
study
ovarian cancer
phase 1
Sutro Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
Published:
2023-01-04
(Crawled : 13:00)
- sutrobio.com
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-52.99%
|
O:
1.37%
H:
4.31%
C:
-0.37%
biopharma
conference
Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer
Published:
2022-12-21
(Crawled : 13:00)
- sutrobio.com
PCVX
|
$61.6
1.27%
1.24%
630K
|
Health Technology
|
37.07%
|
O:
0.22%
H:
3.45%
C:
3.2%
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-43.56%
|
O:
4.79%
H:
1.43%
C:
0.0%
stro-002
biopharma
update
cancer
ovarian cancer
Sutro Biopharma and Vaxcyte Enter into Option Grant Agreement for the Development and Manufacturing Rights of Cell-Free Extract
Published:
2022-12-20
(Crawled : 22:00)
- sutrobio.com
PPRUF
|
News
|
$364.27
1.63%
37.56%
850
|
Consumer Non-Durables
|
-26.97%
|
O:
2.83%
H:
2.66%
C:
-0.36%
PPRUY
|
News
|
$36.96
2.44%
-0.11%
220K
|
Manufacturing
|
-25.53%
|
O:
1.46%
H:
1.58%
C:
0.82%
PCVX
|
$61.6
1.27%
1.24%
630K
|
Health Technology
|
37.07%
|
O:
0.22%
H:
3.45%
C:
3.2%
STRO
|
$3.77
3.86%
3.71%
440K
|
Health Technology
|
-43.56%
|
O:
4.79%
H:
1.43%
C:
0.0%
biopharma
grant
agreement
← Previous
1
2
3
4
5
6
7
8
9
Next →
Gainers vs Losers
73%
27%
Top 10 Gainers
MTTR
|
News
M
|
$4.8
175.86%
63.6%
71M
|
AGBA
|
$2.5
100.0%
56.6%
200M
|
Finance
MLEC
|
$2.47
76.43%
42.62%
78M
|
n/a
NUWE
|
$0.334
29.96%
40.99%
2.5M
|
Manufacturing
EDBL
|
News
|
$6.26
66.49%
40.13%
16M
|
ATGL
|
$2.86
46.25%
32.8%
180K
|
ONFO
|
$0.6088
38.68%
27.74%
7.3M
|
n/a
VIVK
|
$1.43
33.65%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.7M
|
SDIG
A
|
$3.64
35.32%
26.0%
990K
|
Your saved searches
Save your searches and get alerts when important news are released.